FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

22980511000001103: Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Sep 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1896401000001114 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1896421000001119 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Is a Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 10 vial true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has AMP Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start